China Health Technology Group Holding Company Limited (HKG:1069)

Hong Kong · Delayed Price · Currency is HKD

0.2850

+0.0050 (1.79%)

Jul 10, 2026, 3:59 PM HKT

HKG:1069 Financials Overview

Financials in millions CNY. Fiscal year is July - June.

Millions CNY. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	93.5	90.22	47.61	58.72	6.76	-
Revenue Growth	3.64%	89.50%	-18.92%	769.11%	-	-
Gross Profit	9.57	8.21	1.9	11.51	-	-
Operating Income	-6.4	-8.33	-21	-8.41	-11.71	-21.44
Net Income	22.99	22.71	200.01	-10.8	-18.9	-369.09
Earnings Per Share	0.25	0.28	2.98	-0.98	-1.71	-33.48
EPS Growth	-10.20%	-90.77%	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Forestry Business	32.14	36.63	32.52	25.6	6.76
Ginseng Business	40.09	39.47	15.09	33.11	-
Health Products Business	21.27	14.12	-	-	-
Total	93.5	90.22	47.61	58.72	6.76

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Investments	2.6	4.49	3.23	4.33	1.11	1.82
Total Debt	114.71	116.34	119.11	356.78	321.97	306.62
Net Cash (Debt)	-112.11	-111.85	-115.88	-352.45	-320.87	-304.8
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.21	-1.35	-1.73	-31.97	-29.11	-27.65

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Cash Flow	49.43	34.67	28.86	23.44	-0.47	0.11
Capital Expenditures	-35.56	-35.56	-26.49	-23.28	-	-
Free Cash Flow	13.87	-0.89	2.37	0.16	-0.47	0.11
Free Cash Flow Growth	-	-	1350.92%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Gross Margin	10.24%	9.10%	3.98%	19.60%	-	-
Operating Margin	-6.84%	-9.23%	-44.10%	-14.32%	-173.28%	-
Pretax Margin	24.86%	25.52%	420.16%	-15.96%	-301.70%	-
Profit Margin	24.58%	25.17%	420.14%	-18.39%	-279.75%	-
FCF Margin	14.84%	-0.99%	4.97%	0.28%	-6.90%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
PE Ratio	1.04	1.49	0.21	-	-	-
P/FCF Ratio	1.90	-	18.04	625.92	-	951.23
PS Ratio	0.28	0.37	0.90	1.74	13.93	-